These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1751392)
1. The antiglucocorticoid RU486 downregulates the expression of interleukin-2 receptors in normal human lymphocytes. Antonakis N; Markogiannakis E; Theodoropoulou M; Georgoulias V; Stournaras C; Gravanis A J Steroid Biochem Mol Biol; 1991 Dec; 39(6):929-35. PubMed ID: 1751392 [TBL] [Abstract][Full Text] [Related]
2. In vitro differential effects of the antiglucocorticoid RU486 on the release of lymphokines from mitogen-activated normal human lymphocytes. Antonakis N; Georgoulias V; Margioris AN; Stournaras C; Gravanis A J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):67-72. PubMed ID: 7947352 [TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-mediated inhibition of interleukin-2 receptor alpha and -beta subunit expression by human T cells. Batuman OA; Ferrero AP; Diaz A; Berger B; Pomerantz RJ Immunopharmacology; 1994; 27(1):43-55. PubMed ID: 8206753 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Trypanosoma cruzi-induced down-regulation of lymphocyte function. Inhibition of transcription and expression of IL-2 receptor gamma (p64IL-2R) and beta (p70IL-2R) chain molecules in activated normal human lymphocytes. Majumder S; Kierszenbaum F J Immunol; 1996 May; 156(10):3866-74. PubMed ID: 8621925 [TBL] [Abstract][Full Text] [Related]
5. The anti-progestin RU486 stabilizes the progestin-induced fatty acid synthetase mRNA but does not stimulate its transcription. Chalbos D; Galtier F; Emiliani S; Rochefort H J Biol Chem; 1991 May; 266(13):8220-4. PubMed ID: 2022639 [TBL] [Abstract][Full Text] [Related]
6. [RU486 reverses dexamethasone-mediated suppression of IL-2 receptor expressions in lymphocytes of rat spleen]. Liang F; Lü B; Tang P Zhongguo Ying Yong Sheng Li Xue Za Zhi; 1997 Feb; 13(1):50-2. PubMed ID: 10074316 [TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus-infected adherent cell-derived inhibitory factor (p29) inhibits normal T cell proliferation through decreased expression of high affinity interleukin-2 receptors and production of interleukin-2. Ammar A; Sahraoui Y; Tsapis A; Bertoli AM; Jasmin C; Georgoulias V J Clin Invest; 1992 Jul; 90(1):8-14. PubMed ID: 1321845 [TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A inhibits induction of IL-2 receptor alpha chain expression by affecting activation of NF-kB-like factor(s) in cultured human T lymphocytes. Brini AT; Harel-Bellan A; Farrar WL Eur Cytokine Netw; 1990; 1(3):131-9. PubMed ID: 2129797 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of interleukin-2 and apha-chain interleukin-2 receptor biosynthesis by cisplatin in human peripheral lymphocytes. Sfikakis PP; Souliotis VL; Katsilambros N; Markakis K; Vaiopoulos G; Tsokos GC; Panayiotidis P Clin Immunol Immunopathol; 1996 Apr; 79(1):43-9. PubMed ID: 8612350 [TBL] [Abstract][Full Text] [Related]
10. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors. Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor. Burdach S; Zessack N; Dilloo D; Shatsky M; Thompson D; Levitt L J Clin Invest; 1991 Jun; 87(6):2114-21. PubMed ID: 1828253 [TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin 2, interferon-gamma, and the IL 2 receptor by human peripheral blood lymphocytes. Grabstein K; Dower S; Gillis S; Urdal D; Larsen A J Immunol; 1986 Jun; 136(12):4503-8. PubMed ID: 3086434 [TBL] [Abstract][Full Text] [Related]
13. Altered gene transcription after burn injury results in depressed T-lymphocyte activation. Horgan AF; Mendez MV; O'Riordain DS; Holzheimer RG; Mannick JA; Rodrick ML Ann Surg; 1994 Sep; 220(3):342-51; discussion 351-2. PubMed ID: 8092900 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra). Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451 [TBL] [Abstract][Full Text] [Related]
15. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation. Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625 [TBL] [Abstract][Full Text] [Related]
16. Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones. Sztein MB; Serrate SA; Goldstein AL Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6107-11. PubMed ID: 3090550 [TBL] [Abstract][Full Text] [Related]
17. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells. Kasid A; Bell GI; Director EP J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414 [TBL] [Abstract][Full Text] [Related]
18. Evidence from pulse-chase labeling studies that the antiglucocorticoid hormone RU486 stabilizes the nonactivated form of the glucocorticoid receptor in mouse lymphoma cells. Distelhorst CW; Howard KJ J Steroid Biochem; 1990 Jun; 36(1-2):25-31. PubMed ID: 2362447 [TBL] [Abstract][Full Text] [Related]
19. Interleukin 2, interleukin 2 receptor, and interferon-gamma synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans. Chopra RK; Holbrook NJ; Powers DC; McCoy MT; Adler WH; Nagel JE Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):297-308. PubMed ID: 2507204 [TBL] [Abstract][Full Text] [Related]
20. Regulation of IL-2 beta receptor expression and beta-chain mRNA by human thymocytes. Reem GH; Han X; Marcelli A Clin Exp Immunol; 1992 Jan; 87(1):150-6. PubMed ID: 1733630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]